Ichnos Glenmark Innovation

News

AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody

AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.

News

FDA says comparator dose scuppered Moderna's flu jab filing

The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Ichnos Glenmark Innovation

Editor's Picks